drugset / Trial / NCT05875077

Propofol Versus Dexmedetomidine on the Incidence of Postoperative Nausea and Vomiting

NCT05875077 ↗

Unknown 45 enrolled Cairo University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Post-operative nausea and vomiting are a leading cause of recovery room delays and low patient satisfaction. Complications such as suture line tension, wound hemorrhage and dehiscence, elevated intracranial pressure, pulmonary aspiration, dehydration, and electrolyte imbalance have been linked to nausea and vomiting. Many studies were done to explore the effects of propofol and dexmedetomidine on the incidence of post operative nausea and vomiting (PONV). In this study, we will compare propofol infusion to dexmedetomidine infusion on the incidence of PONV in patients undergoing ureteroscopic procedures under spinal anesthesia in the age group from 18 to 60 years with more than one risk factor for PONV (female, history of PONV, non-smoking).

Timeline

Start
2022-05-01
Primary completion
2024-01-01
Completion
2024-02-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.5 ug/kg —
Subject Propofol Small molecule 1 mg/kg —

Indications

No indication recorded.